Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Santeon is a Dutch healthcare collaboration of seven large teaching hospitals that work together to improve care quality, transparency, and value-based healthcare across the Netherlands. Rather than being a drug-development biotech or pharma company, Santeon operates as a hospital network and healthcare innovation organization focused on care-pathway redesign, outcomes measurement, data sharing, and implementation of best practices. Its core enabling technology is the Health Intelligence Platform Santeon (HIPS), a shared data platform used to harmonize and compare clinical and cost data across member hospitals. Santeon runs joint improvement programs such as Samen Beter and uses standardized outcome measurement, digital care initiatives, and shared analytics to support research, care optimization, and patient decision-making. For a biotech analyst, Santeon is best understood as a provider-side healthcare innovation and data collaboration organization, not a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Santeon.